Arrowstreet Capital
BVS icon

Arrowstreet Capital’s Bioventus BVS Stock Holding History

Arrowstreet Capital’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+158,690
New +$1.52M ﹤0.01% 1579
2022
Q2 		– Sell
-87,948
Closed -$1.24M – 1246
2022
Q1 		$1.24M Sell
87,948
-253,561
-74% -$3.39M ﹤0.01% 897
2021
Q4 		$4.95M Buy
341,509
+238,568
+232% +$3.39M 0.01% 821
2021
Q3 		$1.46M Buy
102,941
+92,741
+909% +$1.43M ﹤0.01% 1208
2021
Q2 		$180K Buy
+10,200
New +$164K ﹤0.01% 1793

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital's BVS Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Bioventus (BVS) in Q2 2026: 158,690 shares worth $1.5M. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in BVS as recently as Q1 2022.

Arrowstreet Capital first reported a position in BVS in Q2 2021 and has held it in 5 quarters since. The position peaked at $4.95M in Q4 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Arrowstreet Capital held 158,690 shares of Bioventus worth $1.5M as of Q2 2026.
  • Bioventus was a new Arrowstreet Capital position in Q2 2026.
  • Bioventus made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1579 holding.
  • Arrowstreet Capital first reported a position in Bioventus in Q2 2021 and has held it in 5 quarters since.
  • Arrowstreet Capital's Bioventus position peaked at $4.95M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.